Clinical Trials in Washington

Showing 2561-2580 of 9,462 trials

Measurements of CSF Shunts and Off-Shunt Locations With Wireless Thermal Anisotropy Measurement Devices

NCT06513572

This study collects data using non-invasive devices for assessing CSF shunt flow using thermal anisotropy measurements in a prospective study setting. The study will collect data to compare measurements from flowing shunts, non-flowing shunts, and off-shunt locations.

Hydrocephalus

Rhaeos, Inc.10 participantsStarted Jul 2024

Orange, California, United States • West Hollywood, California, United States • Tampa, Florida, United States +5 more locations

RECRUITINGPhase 1/242 miles

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

NCT04104776

The purpose of this open-label, first-in-human (FIH) trial is to evaluate the safety, tolerability, and preliminary clinical activity of Tulmimetostat as a monotherapy in patients with advanced solid tumors and lymphomas.

Advanced Solid TumorDiffuse Large B Cell LymphomaLymphoma, T-Cell+5 more

Novartis Pharmaceuticals275 participantsStarted Sep 2019

Atlanta, Georgia, United States • Chicago, Illinois, United States • Baltimore, Maryland, United States +57 more locations

Measurements of CSF Shunts and Off-Shunt Locations With Wireless Thermal Anisotropy Measurement Devices

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Find Trials by Condition in Washington

Functional and Non-Functional CSF Shunt Flow Measured With a Second-Generation Wireless Thermal Device

Natural Sunlight Protection and Simulated Sunlight Protection Offered by Sunscreens and Fabrics

Changing the Paradigm of In-Hospital Cardiopulmonary Resuscitation

Decision Making Tool for Firearm Storage

Lenalidomide (Revlimid®, CC-5013) in Subjects With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma

Regorafenib Plus Pembrolizumab in Patients With Advanced or Spreading Liver Cancer Who Have Been Previously Treated With PD-1/PD-L1 Immune Checkpoint Inhibitors

Unrelated Donor Transplant Versus Immune Therapy in Pediatric Severe Aplastic Anemia

Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation

A Study of SEA-CD40 Given With Other Drugs in Cancers

Durvalumab With or Without Tremelimumab in Metastatic Castration Resistant Prostate Cancer

Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol

A Study to Assess Adverse Events and Change in Disease Activity of HArmonyCa Lidocaine Injectable Gel for Mid Face Soft Tissue Augmentation in Adult Participants

This Study Tests Whether BI 409306 Prevents Patients With a Specific Type of Mental Illness (Attenuated Psychosis Syndrome) From Becoming Worse. This Study Looks at How Well Patients Tolerate the Medicine and How Effective it is Over 1 Year

Adalimumab in JIA-associated Uveitis Stopping Trial

A Study of IMR-687 in Adult Participants With Sickle Cell Anemia (Homozygous HbSS or Sickle-β0 Thalassemia)

A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery

Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs

Extension Study to Evaluate the Long-Term Outcomes of Pediatric Patients Who Received Treatment for Retinopathy of Prematurity in the VGFTe-ROP-1920 Study (Acronym: Butterfleye Next)